The report "3D Printed Drugs Market by Dosage Form (Tablet, Capsule, Nanoparticles), Technology (Inkjet Printing, Zipdose, Direct Write, Stereolithography, Fused Deposition Modeling), Application (Orthopedic, Neurology, Dental) - Global Forecast to 2027", is projected to reach USD 110 million by 2027 from ~USD 50 million in 2022, at a CAGR of 17% during the forecast period
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/3d-printed-drugs-market-175432487.html
Factors such as increasing adoption of personalized drugs, growing research and development activities, increasing disease prevalence, increasing availability of individual drugs and the production of combination medications are expected to support the growth of the 3D printed drugs market.
The tablet segment accounted for the largest share of the 3D printed drugs market by application in 2021.
On the basis of technology, the 3D printed drugs market is segmented into inkjet printing, direct write, zip dose, thermal inkjet printing, fused deposition modeling, powder bed printing, stereolithography (SLA), and semi solid extrusion (SSE). In 2021, the zip dose segment accounted for the largest share of the 3D printed drugs market. The key factors driving the growth of this market include ease of use and increasing demand among geriatric & pediatric patients for rapid soluble drugs. On the other hand, inkjet printer technology, is expecetd to grow at a highest CAGR during the forecast period owing to its ability to generates 3D drugs at a steady rate and has technological superiorities over other techniques.
North America to command the largest share of the 3D printed drugs market in 2021
Based on region, the 3D printed drugs market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the 3D printed drugs market in 2021. The growth of the North American market is primarily driven by increased incidence of chronic diseases, the presence of excellent advanced healthcare infrastructure, significant investment in R&D, and technological developments in the North America region.
Prominent players in the 3D printed drugs market include Aprecia Pharmaceuticals LLC (US), Bioduro (US), Acrux (US), AstraZeneca (UK), Biomedical modeling Inc. (US), GlaxoSmithKline Plc (UK), Merck KGaA (Germany), Cycle Pharmaceuticals (UK), among others
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com